Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Mullins

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Experimental Medicine|October 8, 2003
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor controlDavid W Mullins, Stacey L Sheasley, Rebecca M Ream, et al.
The Journal of Biological Chemistry|May 2, 2006
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cellsChien-Chung Chang, Takeshi Ogino, David W Mullins, et al.
International Journal of Molecular Sciences|June 26, 2026
A Rapid 3D Melanoma-Skin Organoid for High-Throughput Assessment of Tumor Dynamics and Drug ResponseGemma Nomdedeu-Sancho, Nicholas Edenhoffer, Anastasiya Gorkun-Roeder, et al.
Cancer Immunology Research|June 7, 2015
Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like DiseaseEleanor Clancy-Thompson, Thomas J Perekslis, Walburga Croteau, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Interferons induce CXCR3-cognate chemokine production by human metastatic melanomaLynn T Dengel, Allison G Norrod, Briana L Gregory, et al.
Pigment Cell & Melanoma Research|January 28, 2014
Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032Molly H Jenkins, Shannon M Steinberg, Matthew P Alexander, et al.
International Journal of Cancer|November 9, 2019
A TLR7 agonist strengthens T and NK cell function during BRAF-targeted therapy in a preclinical melanoma modelLydia Bellmann, Giuseppe Cappellano, Johanna F Schachtl-Riess, et al.
Cancer Research|November 3, 2004
CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III diseaseIrene M Mullins, Craig L Slingluff, Jae K Lee, et al.
Advances in Immunology|May 30, 2006
Immunity to melanoma antigens: from self-tolerance to immunotherapyCraig L Slingluff, Kimberly A Chianese-Bullock, Timothy N J Bullock, et al.
Scientific Reports|April 5, 2020
Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathologyShirin Kalyan, Mark Bazett, Ho Pan Sham, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Experimental Medicine|October 8, 2003
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor controlDavid W Mullins, Stacey L Sheasley, Rebecca M Ream, et al.
The Journal of Biological Chemistry|May 2, 2006
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cellsChien-Chung Chang, Takeshi Ogino, David W Mullins, et al.
International Journal of Molecular Sciences|June 26, 2026
A Rapid 3D Melanoma-Skin Organoid for High-Throughput Assessment of Tumor Dynamics and Drug ResponseGemma Nomdedeu-Sancho, Nicholas Edenhoffer, Anastasiya Gorkun-Roeder, et al.
Cancer Immunology Research|June 7, 2015
Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like DiseaseEleanor Clancy-Thompson, Thomas J Perekslis, Walburga Croteau, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Interferons induce CXCR3-cognate chemokine production by human metastatic melanomaLynn T Dengel, Allison G Norrod, Briana L Gregory, et al.
Pigment Cell & Melanoma Research|January 28, 2014
Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032Molly H Jenkins, Shannon M Steinberg, Matthew P Alexander, et al.
International Journal of Cancer|November 9, 2019
A TLR7 agonist strengthens T and NK cell function during BRAF-targeted therapy in a preclinical melanoma modelLydia Bellmann, Giuseppe Cappellano, Johanna F Schachtl-Riess, et al.
Cancer Research|November 3, 2004
CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III diseaseIrene M Mullins, Craig L Slingluff, Jae K Lee, et al.
Advances in Immunology|May 30, 2006
Immunity to melanoma antigens: from self-tolerance to immunotherapyCraig L Slingluff, Kimberly A Chianese-Bullock, Timothy N J Bullock, et al.
Scientific Reports|April 5, 2020
Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathologyShirin Kalyan, Mark Bazett, Ho Pan Sham, et al.
Pageof 4